Q2 2016 Holdings
Filed 2016-08-12 | 18 holdings | $5.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ardelyx, Inc.(ARDX) | COM | 039697107 | $5.3M | 601,485 | 97.4% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $40.0K | 1,600,183 | 0.7% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $23.7K | 1,345,313 | 0.4% |
| Wave Life Sciences Ltd.(WVE) | SHS | Y95308105 | $20.1K | 970,104 | 0.4% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $16.3K | 763,688 | 0.3% |
| Global Blood Therapeutics, Inc. | COM | 37890U108 | $11.5K | 690,269 | 0.2% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $5.2K | 511,777 | 0.1% |
| Avexis, Inc. | COM | 05366U100 | $3.6K | 95,173 | 0.1% |
| NeuroDerm Ltd. | ORD SHS | M74231107 | $3.3K | 201,469 | 0.1% |
| Zafgen, Inc. | COM | 98885E103 | $3.2K | 537,495 | 0.1% |
| Syros Pharmaceuticals, Inc. | COM | 87184Q107 | $2.7K | 150,000 | 0.1% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $2.7K | 205,990 | 0.0% |
| Akari Therapeutics, PLC | SPONSORED ADR | 00972G108 | $2.7K | 197,072 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $2.5K | 235,020 | 0.0% |
| Orexigen Therapeutics, Inc. | COM | 686164104 | $1.1K | 2,542,575 | 0.0% |
| Lipocine Inc. | COM | 53630X104 | $920 | 302,640 | 0.0% |
| NanoString Technologies, Inc.(NSTGEUR) | COM | 63009R109 | $895 | 71,000 | 0.0% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | COM | 09060J106 | $166 | 70,177 | 0.0% |